Healthcare stocks rank high on our like list, boasting a history of resilience amid both inflation and recession as well as attractive growth prospects thanks to potent innovation. Dr. Erin Xie examines the opportunity.

Amid optimism for a COVID-19 vaccine and greater clarity around the U.S. election, Dr. Erin Xie, portfolio manager of the BlackRock Health Sciences Opportunities Fund, discusses two timely reasons to consider healthcare stocks.